Pınar, İbrahim Ethem, and Vildan Ozkocaman. “Efficacy and Safety Outcomes of Single-Agent Ibrutinib Therapy in Chronic Lymphocytic Leukemia and Relapsed Refractory Mantle-Cell Lymphoma”. The European Research Journal 9, no. 6 (November 3, 2023): 1483–1492. Accessed May 22, 2026. https://www.eurj.org.tr/article/view/874.